FAK inhibition alone or in combination with adjuvant therapies reduces cancer stem cell activity

por Simon Timbrell, Hosam Aglan, Angela Cramer, Phil Foden, David Weaver, Jonathan Pachter, Aoife Kilgallon, Robert B. Clarke, Gillian Farnie, Nigel J. Bundred
Publicado 2021

Radiation recall dermatitis following letrozole administration in patient with a remote history of radiation therapy

por Evan Sweren, Pathik Aravind, Robert Dembinski, Catherine Klein, Mehran Habibi, Michelle L. Kerns
Publicado 2021

MicroRNA-200c restoration reveals a cytokine profile to enhance M1 macrophage polarization in breast cancer

por Michelle M. Williams, Jessica L. Christenson, Kathleen I. O’Neill, Sabrina A. Hafeez, Claire L. Ihle, Nicole S. Spoelstra, Jill E. Slansky, Jennifer K. Richer
Publicado 2021

Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer

por Wei-Gang Qiu, Alla Polotskaia, Gu Xiao, Lia Di, Yuhan Zhao, Wenwei Hu, John Philip, Ronald C. Hendrickson, Jill Bargonetti
Publicado 2017

Moonshots and metastatic disease: the need for a multi-faceted approach when studying atypical responses

por Kristine De La Torre, Elly Cohen, Anne Loeser, Marc Hurlbert, on behalf of the Metastatic Breast Cancer Alliance
Publicado 2017

CREATE-X a role for capecitabine in early-stage breast cancer: an analysis of available data

por Jo Anne Zujewski, Lawrence Rubinstein
Publicado 2017

Human snoRNA-93 is processed into a microRNA-like RNA that promotes breast cancer cell invasion

por Dillon G. Patterson, Justin T. Roberts, Valeria M. King, Dominika Houserova, Emmaline C. Barnhill, Aline Crucello, Caroline J. Polska, Lucas W. Brantley, Garrett C. Kaufman, Michael Nguyen, Megann W. Santana, Ian A. Schiller, Julius S. Spicciani, Anastasia K. Zapata, Molly M. Miller, Timothy D. Sherman, Ruixia Ma, Hongyou Zhao, Ritu Arora, Alexander B. Coley, Melody M. Zeidan, Ming Tan, Yaguang Xi, Glen M. Borchert
Publicado 2017

Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12

por Brile Chung, Ali A. Esmaeili, Sailesh Gopalakrishna-Pillai, John P. Murad, Emily S. Andersen, Naveen Kumar Reddy, Gayathri Srinivasan, Brian Armstrong, Caleb Chu, Young Kim, Tommy Tong, James Waisman, John H. Yim, Behnam Badie, Peter P. Lee
Publicado 2017

Long non-coding RNA MIR200CHG promotes breast cancer proliferation, invasion, and drug resistance by interacting with and stabilizing YB-1

por Li Tang, Da Wei, Xinyu Xu, Xuelian Mao, Dongping Mo, Linping Yan, Weiguo Xu, Feng Yan
Publicado 2021

Evaluation of overall survival and barriers to surgery for patients with breast cancer treated without surgery: a National Cancer Database analysis

por D. Boyce-Fappiano, I. Bedrosian, Y. Shen, H. Lin, O. Gjyshi, A. Yoder, S. F. Shaitelman, W. A. Woodward
Publicado 2021

Novel emerging biomarkers to immunotherapy in kidney cancer

por Yasser Ged, Martin H. Voss
Publicado 2021

Surrogate endpoints for early-stage breast cancer: a review of the state of the art, controversies, and future prospects

por María Gion, José Manuel Pérez-García, Antonio Llombart-Cussac, Miguel Sampayo-Cordero, Javier Cortés, Andrea Malfettone
Publicado 2021

Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer

por Inken Flörkemeier, Tamara N. Steinhauer, Nina Hedemann, Magnus Ölander, Per Artursson, Bernd Clement, Dirk O. Bauerschlag
Publicado 2021

PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting

por Laura Pizzuti, Eriseld Krasniqi, Isabella Sperduti, Maddalena Barba, Teresa Gamucci, Maria Mauri, Enzo Maria Veltri, Icro Meattini, Rossana Berardi, Francesca Sofia Di Lisa, Clara Natoli, Mirco Pistelli, Laura Iezzi, Emanuela Risi, Nicola D’Ostilio, Silverio Tomao, Corrado Ficorella, Katia Cannita, Ferdinando Riccardi, Alessandra Cassano, Emilio Bria, Maria Agnese Fabbri, Marco Mazzotta, Giacomo Barchiesi, Andrea Botticelli, Giuliana D’Auria, Anna Ceribelli, Andrea Michelotti, Antonio Russo, Beatrice Taurelli Salimbeni, Giuseppina Sarobba, Francesco Giotta, Ida Paris, Rosa Saltarelli, Daniele Marinelli, Domenico Corsi, Elisabetta Maria Capomolla, Valentina Sini, Luca Moscetti, Lucia Mentuccia, Giuseppe Tonini, Mimma Raffaele, Luca Marchetti, Mauro Minelli, Enzo Maria Ruggeri, Paola Scavina, Olivia Bacciu, Nello Salesi, Lorenzo Livi, Nicola Tinari, Antonino Grassadonia, Angelo Fedele Scinto, Rosalinda Rossi, Maria Rosaria Valerio, Elisabetta Landucci, Simonetta Stani, Beatrice Fratini, Marcello Maugeri-Saccà, Michele De Tursi, Angela Maione, Daniele Santini, Armando Orlandi, Vito Lorusso, Enrico Cortesi, Giuseppe Sanguineti, Paola Pinnarò, Federico Cappuzzo, Lorenza Landi, Claudio Botti, Federica Tomao, Sonia Cappelli, Giulia Bon, Fabio Pelle, Flavia Cavicchi, Elena Fiorio, Jennifer Foglietta, Simone Scagnoli, Paolo Marchetti, Gennaro Ciliberto, Patrizia Vici
Publicado 2021

Systematic Review and Meta-Analysis of Lysine-Specific Demethylase 1 Expression as a Prognostic Biomarker of Cancer Survival and Disease Progression

por Clement Agboyibor, Jianshu Dong, Clement Y. Effah, Emmanuel K. Drokow, Waqar Pervaiz, Dié Li, Lei Kang, Xinli Ma, Jian Li, Zhenzhen Liu, Hong-Min Liu
Publicado 2021

Sparse Regression in Cancer Genomics: Comparing Variable Selection and Predictions in Real World Data

por Robert J O’Shea, Sophia Tsoka, Gary JR Cook, Vicky Goh
Publicado 2021

Locoregional recurrence of triple-negative breast cancer: effect of type of surgery and adjuvant postoperative radiotherapy

por Bayoumi Y, AbdelSamie A, Abdelsaid A, Radwan A
Publicado 2014

Keeping an open mind: highlights and controversies of the breast cancer stem cell theory

por Shah M, Allegrucci C
Publicado 2012

Emerging targeted combinations in the management of breast cancer

por Lee RJ, Armstrong AC, Wardley AM
Publicado 2013

Palbociclib: an evidence-based review of its potential in the treatment of breast cancer

por Cadoo KA, Gucalp A, Traina TA
Publicado 2014